Immunology
Global

Immunology Experts

Sergio Traversa, Pharmd, Mba

Chief Executive Officer and Interim Chief Financia
immunology
Relmada Therapeutics
Iraq

Biography

Before joining Relmada, Dr. Traversa was the co-founder and CEO of Medeor Inc. a spinoff pharmaceutical company from Cornell University. Dr. Traversa has over twenty-five years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the pharmaceutical industry to investing and strategic advisory roles. He has held financial analyst, portfolio management and strategic advisory positions at large U.S. investment firms specializing in healthcare, including Mehta and Isaly and Mehta partners, ING Barings, Merlin BioMed and Rx Capital. Dr. Traversa was a founding partner of Ardana Capital, a pharmaceutical and biotechnology investment advisory firm. In Europe, he held the position of Area Manager for Southern Europe of Therakos Inc., a cancer and immunology division of Johnson & Johnson. Prior to Therakos, Dr. Traversa was at Eli Lilly, where he served as Marketing Manager of the Hospital Business Unit. He was also a member of the CNS team at Eli Lilly, where he participated in the launch of Prozac and the early development of Zyprexa and Cymbalta. Dr. Traversa started his career as a sales representative at Farmitalia Carlo Erba, the largest pharmaceutical company in Italy later sold to Pharmacia and now part of Pfizer. Dr. Traversa holds a Laurea degree in Pharmacy from the University of Turin (Italy) and an MBA in Finance and International Business from the New York University Leonard Stern School of Business.

Research Interest

Before joining Relmada, Dr. Traversa was the co-founder and CEO of Medeor Inc. a spinoff pharmaceutical company from Cornell University. Dr. Traversa has over twenty-five years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the pharmaceutical industry to investing and strategic advisory roles. He has held financial analyst, portfolio management and strategic advisory positions at large U.S. investment firms specializing in healthcare, including Mehta and Isaly and Mehta partners, ING Barings, Merlin BioMed and Rx Capital. Dr. Traversa was a founding partner of Ardana Capital, a pharmaceutical and biotechnology investment advisory firm. In Europe, he held the position of Area Manager for Southern Europe of Therakos Inc., a cancer and immunology division of Johnson & Johnson. Prior to Therakos, Dr. Traversa was at Eli Lilly, where he served as Marketing Manager of the Hospital Business Unit. He was also a member of the CNS team at Eli Lilly, where he participated in the launch of Prozac and the early development of Zyprexa and Cymbalta. Dr. Traversa started his career as a sales representative at Farmitalia Carlo Erba, the largest pharmaceutical company in Italy later sold to Pharmacia and now part of Pfizer. Dr. Traversa holds a Laurea degree in Pharmacy from the University of Turin (Italy) and an MBA in Finance and International Business from the New York University Leonard Stern School of Business.

Global Experts from Iraq

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 9th Molecular Immunology & Immunogenetics Congress

    March 08-09, 2018 London, UK

  • Immunology and Cell biology

    May 11-12, 2018 Osaka, Japan

  • Global Summit on Immunology and Cell biology

    May 11-12, 2018 Osaka, Japan

  • Antibody Engineering Meeting associated with 9th European Immunology Conference

    June 14-16 2018 Rome, Italy

  • Antibody Engineering Meeting associated with 9th European Immunology Conference

    June 14-16 2018 Rome, Italy

  • International Conference on Clinical and Cellular Immunology

    August 6-7, 2018 Madrid, Spain

  • International Conference on Tumor & Cancer Immunology and Immunotherapy

    September 17-18, 2018 San Diego, USA

  • 10th World Congress and Expo on Immunology

    October 19-20, 2018 Baltimore, USA

  • World Congress and Expo on Immunology

    October 19-20, 2018 Baltimore, USA

  •  Theme: Novel Research and Therapeutic Challenges in Antibodies and Antibiotics

    December 05-06, 2018 Chicago, USA

View more
Relevant Topics